Texas A&M Institute for Neuroscience, Department of Psychology, Texas A&M University, College Station, TX 77843-4235, USA.
Exp Neurol. 2013 Sep;247:328-41. doi: 10.1016/j.expneurol.2013.03.008. Epub 2013 Mar 15.
Approximately one-third of people with a spinal cord injury (SCI) will experience persistent neuropathic pain following injury. This pain negatively affects quality of life and is difficult to treat. Opioids are among the most effective drug treatments, and are commonly prescribed, but experimental evidence suggests that opioid treatment in the acute phase of injury can attenuate recovery of locomotor function. In fact, spinal cord injury and opioid administration share several common features (e.g. central sensitization, excitotoxicity, aberrant glial activation) that have been linked to impaired recovery of function, as well as the development of pain. Despite these effects, the interactions between opioid use and spinal cord injury have not been fully explored. A review of the literature, described here, suggests that caution is warranted when administering opioids after SCI. Opioid administration may synergistically contribute to the pathology of SCI to increase the development of pain, decrease locomotor recovery, and leave individuals at risk for infection. Considering these negative implications, it is important that guidelines are established for the use of opioids following spinal cord and other central nervous system injuries.
约三分之一的脊髓损伤(SCI)患者在受伤后会持续出现神经性疼痛。这种疼痛会降低生活质量,且难以治疗。阿片类药物是最有效的药物治疗方法之一,通常被开处方,但实验证据表明,阿片类药物在损伤的急性期治疗可能会减弱运动功能的恢复。事实上,脊髓损伤和阿片类药物的使用有一些共同的特征(例如中枢敏化、兴奋性毒性、异常胶质细胞激活),这些特征与功能恢复受损以及疼痛的发展有关。尽管有这些影响,但阿片类药物使用与脊髓损伤之间的相互作用尚未得到充分探讨。这里描述的文献综述表明,在 SCI 后使用阿片类药物时需要谨慎。阿片类药物的使用可能会协同导致 SCI 的病理学发展,增加疼痛的发生,减少运动功能的恢复,并使个体面临感染的风险。考虑到这些负面影响,为脊髓和其他中枢神经系统损伤后的阿片类药物使用制定指南非常重要。